What Sextant Sees

GSS: 58 | Resonance: 0 | Tension: neutral
Active Patterns: None
Theoretical: The Tidal Wave, FOMO Ignition, Wrong Consensus Meets Deadline
Dimensions: M:9.0 C:4.8 D:3 S:4 CP:1 Mg-Q:6 Mg-T:7
Velocity: fading: C_options_anomaly -2 (5 scans)

The Chokepoint

QUBT controls thin-film lithium niobate chip manufacturing through its Fab 1 facility in Arizona and the $110 million Luminar Semiconductor acquisition completed February 2026. The Fab 1 facility manufactures specialized photonic integrated circuits that generate early revenue through external customer engagements. The Luminar acquisition adds established customer relationships and accelerates manufacturing scale. Room-temperature quantum machines operating without expensive cooling systems differentiate them from competitors.

Why It Flagged Today

The scanner caught QUBT at peak technical distress. Trading at $6.66 with a 52-week range of $5.76-$25.84 means the stock sits 74% below its high. Cantor Fitzgerald cut the price target from $15 to $10 on March 3rd. Recent quarterly results flagged widening losses and minimal revenues relative to operating expenses. High short interest and put ratios signal maximum pessimism.

Watch For

Earnings date estimated May 11, 2026. Expected 3600.9% revenue improvement for 2026 provides the binary catalyst. Fab 2 facility announcements and external foundry partnerships could validate the manufacturing strategy before summer.

The Asymmetry

Upside: $737.9 million cash position funds operations through 2028 while photonics demand accelerates across AI and defense sectors. Downside: Low unit volumes, lengthy sales cycles and customization requirements limit repeatability and near-term revenue expansion.

SIGNAL GSS 58 with neutral tension suggests bottom-fishing territory. Sector rotation into financials, industrials, and utilities pulls capital from quantum names into value plays. Wait for earnings catalyst or GSS breach of 40.

Full entry window, exit conditions, and score trajectory available to Pro members at damonskyeresearch.com

The author may hold positions in securities discussed in this publication. All positions, if any, will be consistent with the analytical thesis presented. DamonSkye Research discloses material holdings at the time of publication. This is not investment advice. See full disclaimer.